Diabetes Mellitus, Type 2
Showing NaN - NaN of 139
Diabetes, Type 2 Trial in Brampton, Etobicoke, Toronto (Basal insulin glargine and lixisenatide, Basal insulin Basaglar/Lantus +
Completed
- Diabetes Mellitus, Type 2
- Basal insulin glargine and lixisenatide
- +2 more
-
Brampton, Ontario, Canada
- +2 more
Feb 24, 2021
Coronary Arteriosclerosis, Diabetes, Type 2, Cerebrovascular Accident Trial in Worldwide (Atorvastatin (Lipitor))
Completed
- Coronary Arteriosclerosis
- +4 more
- Atorvastatin (Lipitor)
-
Mississauga, Ontario, Cameroon
- +120 more
Feb 17, 2021
Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, oral )
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- semaglutide
- oral placebo
-
Tucson, Arizona
- +102 more
Jan 14, 2021
Diabetes, Type 2 Trial in Worldwide (Insulin degludec, Insulin glargine)
Completed
- Diabetes Mellitus, Type 2
- Insulin degludec
- Insulin glargine
-
Chandler, Arizona
- +66 more
Dec 16, 2020
Diabetes, Type 2 Trial in Worldwide (Albiglutide, Insulin Glargine and Insulin Lispro)
Completed
- Diabetes Mellitus, Type 2
- Albiglutide
- Insulin Glargine and Insulin Lispro
-
Searcy, Arkansas
- +157 more
Nov 13, 2020
Diabetes, Type 2 Trial in Worldwide (MEDI0382 low dose, MEDI0382 mid dose, MEDI0382 high dose)
Completed
- Diabetes Mellitus, Type 2
- MEDI0382 low dose
- +4 more
-
Birmingham, Alabama
- +118 more
Jul 31, 2020
Diabetes, Type 1, Diabetes, Type 2, Obesity Trial in Toronto (Empagliflozin, Placebo (matching empagliflozin), ramipril)
Completed
- Diabetes Mellitus, Type 1
- +2 more
- Empagliflozin
- +2 more
-
Toronto, Ontario, CanadaToronto General Hospital
Jul 23, 2020
Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, alpha-glucosidase inhibitors, DPP-4 inhibitors)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- liraglutide
- +6 more
-
Birmingham, Alabama
- +231 more
Jun 16, 2020
Diabetes, Type 2 Trial in Worldwide (Dulaglutide)
Completed
- Diabetes Mellitus, Type 2
-
Chandler, Arizona
- +207 more
May 28, 2020
Diabetes, Type 2 Trial in Worldwide (Ticagrelor 60 mg, Ticagrelor )
Completed
- Diabetes Mellitus, Type 2
- Ticagrelor 60 mg
- Ticagrelor placebo
-
Alexander City, Alabama
- +1241 more
Mar 4, 2020
Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, )
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- semaglutide
- placebo
-
Anniston, Alabama
- +118 more
Feb 14, 2020
Diabetes, Diabetes, Type 2 Trial in Worldwide (Semaglutide, Canagliflozin, Placebo (canagliflozin))
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- Semaglutide
- +3 more
-
Anaheim, California
- +118 more
Jan 8, 2020
Diabetes, Type 2 Trial in Worldwide (linagliptin, glimepiride, linagliptin )
Tresiba® After Switching Basal Insulin inPopulation With Type 1
Completed
- Diabetes Mellitus, Type 1
- Diabetes Mellitus, Type 2
- Insulin degludec
-
Calgary, Alberta, Canada
- +31 more
Dec 5, 2019
Diabetes, Type 2, Diabetic Nephropathy Trial in Worldwide (Canagliflozin, Placebo)
Completed
- Diabetes Mellitus, Type 2
- Diabetic Nephropathy
- Canagliflozin
- Placebo
-
Birmingham, Alabama
- +592 more
Dec 4, 2019
Prediction of Neuropathy in Type 1 Diabetes
Completed
- Diabetic Polyneuropathy
- +4 more
- Exposure: Corneal nerve fibre morphology by the CCM Procedure
-
Ann Arbor, Michigan
- +4 more
Nov 4, 2019
Viscous Fiber on Glycemic Control in Individuals With Diabetes
Completed
- Diabetes Mellitus, Type 1
- Diabetes Mellitus, Type 2
- Viscous Fiber
-
Toronto, Ontario, CanadaClinical Nutrition and Risk Factor Modification Centre
Oct 28, 2019
Cardiovascular Disease, Diabetes, Type 2 Trial in Worldwide (Dulaglutide, Placebo)
Completed
- Cardiovascular Disease
- Diabetes Mellitus, Type 2
- Dulaglutide
- Placebo
-
Mobile, Alabama
- +300 more
Sep 18, 2019
Diabetes, Type 2 Trial in Canada, United States (Insulin glargine, 300 U/ml, Insulin glargine, 100 U/ml, Insulin detemir)
Completed
- Diabetes Mellitus, Type 2
- Insulin glargine, 300 U/ml
- +3 more
-
Birmingham, Alabama
- +426 more
Aug 28, 2019
Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, )
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- liraglutide
- placebo
-
Alabaster, Alabama
- +427 more
Jul 3, 2019
Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, )
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- semaglutide
- placebo
-
Birmingham, Alabama
- +252 more
Jun 20, 2019
Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, )
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- semaglutide
- placebo
-
Anniston, Alabama
- +85 more
May 28, 2019
Diabetes, Type 2, Diabetes, Type 1 Trial in Toronto (a mail letter, a phone call and a phone call plus mailed letter)
Unknown status
- Diabetes Mellitus, Type 2
- Diabetes Mellitus, Type 1
- a mail letter, a phone call and a phone call plus mailed letter
-
Toronto, Ontario, Canada
- +1 more
Apr 23, 2019